Literature DB >> 31267471

The Relationship Between Hypermobile Ehlers-Danlos Syndrome (hEDS), Postural Orthostatic Tachycardia Syndrome (POTS), and Mast Cell Activation Syndrome (MCAS).

Alison Kohn1, Christopher Chang2,3,4,5.   

Abstract

In recent years, an association between hypermobile Ehlers-Danlos syndrome (hEDS), mast cell activation syndrome (MCAS), and postural orthostatic tachycardia syndrome (POTS) has garnered attention and patients are increasingly presenting with this triad. However, a real relationship between these entities is unclear due to a lack of scientific validity. We conducted an extensive review of the literature using two different search strategies. A narrower strategy included 88 searches of various combinations of terms for each of the three conditions, yielding 19 unique papers. A broader search included 136 searches of various combinations of terms but included all forms of EDS and yielded 40 unique papers. Of these, only four and nine papers from the narrower and broader search strategies were original research articles. None of these papers resulted from a combination of the search terms for the three conditions. All three clinical entities are controversial in either existence or pathogenesis. MCAS is a poorly defined clinical entity, and many studies do not adhere to the proposed criteria when establishing the diagnosis. Patients previously diagnosed with EDS hypermobility type may not meet the new, stricter criteria for hEDS but may for a less severe hypermobility spectrum disorder (HSD). The pathophysiology of POTS is still unclear. An evidence-based, common pathophysiologic mechanism between any of the two, much less all three conditions, has yet to be described. Our review of the literature shows that current evidence is lacking on the existence of MCAS or hEDS as separate or significant clinical entities. Studies proposing a relationship between the three clinical entities are either biased or based on outdated criteria. The reason behind the purported association of these entities stems from an overlapping pool of vague, subjective symptoms, which is inadequate evidence to conclude that any such relationship exists.

Entities:  

Keywords:  Fibromyalgia; Hypermobile Ehlers-Danlos syndrome; Leaky gut; Mast cell activation syndrome; Mast cell disorder; Postural orthostatic tachycardia syndrome

Mesh:

Year:  2020        PMID: 31267471     DOI: 10.1007/s12016-019-08755-8

Source DB:  PubMed          Journal:  Clin Rev Allergy Immunol        ISSN: 1080-0549            Impact factor:   8.667


  17 in total

Review 1.  The challenges of chronic pain and fatigue.

Authors:  Jessica A Eccles; Kevin A Davies
Journal:  Clin Med (Lond)       Date:  2021-01       Impact factor: 2.659

Review 2.  The Myth of Mycotoxins and Mold Injury.

Authors:  Christopher Chang; M Eric Gershwin
Journal:  Clin Rev Allergy Immunol       Date:  2019-12       Impact factor: 8.667

Review 3.  Sinus Tachycardia: a Multidisciplinary Expert Focused Review.

Authors:  Kenneth A Mayuga; Artur Fedorowski; Fabrizio Ricci; Rakesh Gopinathannair; Jonathan Walter Dukes; Christopher Gibbons; Peter Hanna; Dan Sorajja; Mina Chung; David Benditt; Robert Sheldon; Mirna B Ayache; Hiba AbouAssi; Kalyanam Shivkumar; Blair P Grubb; Mohamed H Hamdan; Stavros Stavrakis; Tamanna Singh; Jeffrey J Goldberger; James A S Muldowney; Mark Belham; David C Kem; Cem Akin; Barbara K Bruce; Nicole E Zahka; Qi Fu; Erik H Van Iterson; Satish R Raj; Fetnat Fouad-Tarazi; David S Goldstein; Julian Stewart; Brian Olshansky
Journal:  Circ Arrhythm Electrophysiol       Date:  2022-09-08

4.  Recommendations for the recognition, diagnosis, and management of long COVID.

Authors:  Huw Jenkins
Journal:  Br J Gen Pract       Date:  2022-05-26       Impact factor: 6.302

5.  Skin sympathetic nerve activity in patients with chronic orthostatic intolerance.

Authors:  Andrew Lee; Xiao Liu; Carine Rosenberg; Sanjana Borle; Daerin Hwang; Lan S Chen; Xiaochun Li; Noel Bairey Merz; Peng-Sheng Chen
Journal:  Heart Rhythm       Date:  2022-03-17       Impact factor: 6.779

6.  Are patients with hypermobile Ehlers-Danlos syndrome or hypermobility spectrum disorder so different?

Authors:  Bérengère Aubry-Rozier; Adrien Schwitzguebel; Flore Valerio; Joelle Tanniger; Célia Paquier; Chantal Berna; Thomas Hügle; Charles Benaim
Journal:  Rheumatol Int       Date:  2021-08-16       Impact factor: 2.631

7.  Opioid-free anesthesia for patients with joint hypermobility syndrome undergoing craneo-cervical fixation: a case-series study focused on anti-hyperalgesic approach.

Authors:  Carlos Ramírez-Paesano; Albert Juanola Galceran; Claudia Rodiera Clarens; Vicenҫ Gilete García; Bartolomé Oliver Abadal; Verónica Vilchez Cobo; Bibiana Ros Nebot; Sara Julián González; Lucía Cao López; Jesús Santaliestra Fierro; Josep Rodiera Olivé
Journal:  Orphanet J Rare Dis       Date:  2021-04-13       Impact factor: 4.123

Review 8.  Ehlers-Danlos Syndrome: Immunologic contrasts and connective tissue comparisons.

Authors:  Mareesa Islam; Christopher Chang; M Eric Gershwin
Journal:  J Transl Autoimmun       Date:  2020-12-20

Review 9.  Postural Orthostatic Tachycardia Syndrome (POTS): A critical assessment.

Authors:  Brian Olshansky; David Cannom; Artur Fedorowski; Julian Stewart; Christopher Gibbons; Richard Sutton; Win-Kuang Shen; James Muldowney; Tae Hwan Chung; Suzy Feigofsky; Hemal Nayak; Hugh Calkins; David G Benditt
Journal:  Prog Cardiovasc Dis       Date:  2020-03-25       Impact factor: 11.278

10.  Joint Hypermobility Syndrome in Patients With Functional Dyspepsia.

Authors:  Florencia Carbone; Asma Fikree; Qasim Aziz; Jan Tack
Journal:  Clin Transl Gastroenterol       Date:  2020-11       Impact factor: 4.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.